Filing metadata

Accession number
0001415889-24-020688
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Aug 02, 2024
Reporting period
Jul 31, 2024
Description
Insider transaction

Explore SEC Filings Hub